K22.70 Barrett's esophagus without dysplasia

Name of the Condition

• Barrett's esophagus without dysplasia

Summary

Barrett's esophagus without dysplasia is a condition where the normal lining of the lower esophagus is replaced by tissue similar to the intestinal lining, without evidence of precancerous changes. This replacement occurs as a response to chronic acid exposure, typically from gastroesophageal reflux disease (GERD). The condition is monitored due to its association with an increased risk of esophageal adenocarcinoma over time.

Causes

The primary cause is chronic gastroesophageal reflux, which leads to repeated injury and healing of the esophageal lining. Over time, this process can trigger metaplastic changes, replacing the squamous epithelium with columnar epithelium. Other contributing factors may include prolonged acid exposure, bile reflux, or genetic predispositions.

Risk Factors

• Chronic gastroesophageal reflux disease (GERD)
• Obesity, particularly abdominal obesity
• Male gender
• Age (more common in individuals over 50)
• Tobacco use
• Hiatal hernia

Symptoms

• Chronic heartburn or acid reflux
• Difficulty swallowing (dysphagia)
• Chest pain unrelated to heartburn
• Regurgitation of food or liquid
• Unexplained weight loss (less common)

Diagnosis

Diagnosis involves upper endoscopy with biopsy to confirm the presence of Barrett's esophagus and rule out dysplasia. Endoscopic findings may show a salmon-colored, velvety lining in the distal esophagus. Biopsies are taken to assess cellular changes and exclude precancerous or cancerous lesions.

Treatment Options

• Proton pump inhibitors (PPIs) to reduce acid production and manage reflux symptoms
• Lifestyle modifications, such as weight loss and dietary changes
• Endoscopic surveillance to monitor for dysplasia
• In rare cases, endoscopic therapies (e.g., radiofrequency ablation) may be considered if dysplasia develops

Prognosis and Follow-Up

The prognosis is generally favorable when dysplasia is absent, but regular endoscopic surveillance is recommended to detect early changes. Follow-up intervals depend on biopsy results and risk factors, typically every 3–5 years for uncomplicated cases. Early detection of dysplasia significantly improves outcomes.

Complications

• Progression to low-grade or high-grade dysplasia
• Increased risk of esophageal adenocarcinoma
• Strictures or narrowing of the esophagus
• Bleeding from esophageal ulcers

Lifestyle & Prevention

• Maintain a healthy weight to reduce abdominal pressure
• Avoid trigger foods (e.g., spicy, fatty, or acidic items)
• Elevate the head of the bed to minimize reflux
• Quit smoking and limit alcohol consumption
• Eat smaller, more frequent meals

When to Seek Professional Help

Seek medical attention if you experience persistent heartburn, difficulty swallowing, unexplained weight loss, or chest pain. These symptoms may indicate complications or progression to dysplasia.

Tips for Medical Coders

Document the absence of dysplasia in clinical notes, as this is a key distinction for coding. Ensure endoscopic findings and biopsy results are clearly recorded to support the diagnosis. Use this code only when dysplasia is explicitly ruled out or not present.